NPI: 1255638839 · SIKESTON, MO 63801 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/17/2011
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/17/2011 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 27,059 | $350K |
| 2019 | 26,927 | $291K |
| 2020 | 22,445 | $305K |
| 2021 | 18,247 | $181K |
| 2022 | 13,863 | $129K |
| 2023 | 9,367 | $131K |
| 2024 | 4,015 | $76K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 40,176 | 2,847 | $1.46M |
| J3490 | Unclassified drugs | 8,946 | 639 | $680.40 |
| J1756 | Injection, iron sucrose, 1 mg | 4,805 | 1,180 | $0.00 |
| 83540 | 1,993 | 1,844 | $0.00 | |
| 83970 | 1,783 | 1,576 | $0.00 | |
| 85041 | 2,068 | 1,909 | $0.00 | |
| 85048 | 2,058 | 1,904 | $0.00 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 196 | 114 | $0.00 |
| 82108 | 353 | 339 | $0.00 | |
| 85045 | 15 | 15 | $0.00 | |
| 90662 | 13 | 13 | $0.00 | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 32,710 | 1,527 | $0.00 |
| 83550 | 1,896 | 1,753 | $0.00 | |
| J1270 | Injection, doxercalciferol, 1 mcg | 17,437 | 1,396 | $0.00 |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 2,616 | 212 | $0.00 |
| A4657 | Syringe, with or without needle, each | 2,082 | 1,953 | $0.00 |
| 82607 | 73 | 67 | $0.00 | |
| 82728 | 1,996 | 1,851 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 414 | 331 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 134 | 126 | $0.00 |
| 86706 | 14 | 14 | $0.00 | |
| 90674 | 56 | 50 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 31 | 27 | $0.00 |
| 82746 | 58 | 53 | $0.00 |